Correlation of dose-intensity and efficacy of gemcitabine/carboplatin in platinum-sensitive recurrent ovarian cancer (PSOC): subanalysis of the AGO-OVAR 2.5 phase-III-trial by Dr. Sven Mahner given during the 17th International Meeting of the European Society of Gynaecological Oncology (ESGO) powered by - MULTIWEBCAST

17th International Meeting of the European Society of Gynaecological Oncology (ESGO)

LIST OF PRESENTATIONS/COURSES

LISTING OF ePOSTERS

OTHER WEBCASTS

ePosters

BROWSE:

ALL ePOSTERS

PRESENTERS

Correlation of dose-intensity and efficacy of gemcitabine/carboplatin in platinum-sensitive recurrent ovarian cancer (PSOC): subanalysis of the AGO-OVAR 2.5 phase-III-trial

Dr. Sven Mahner

Germany

Topic: Ovarian Cancer

VIEW ePOSTER

14 slide(s) – English – 2011-09-11

Rate & Comment

A A A


Rate:
Please let us know how useful this content was for you and feel free to write your comments below.

Disclaimer ^{AMENDED ON January 29, 2009} | Technical Support

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.

Search’n Build™